Kaur M - Search Results

1

Rabies vaccines: where do we stand, where are we heading?

Kaur M, Garg R, Singh S, Bhatnagar R. Kaur M, et al. Expert Rev Vaccines. 2015 Mar;14(3):369-81. doi: 10.1586/14760584.2015.973403. Epub 2014 Oct 28. Expert Rev Vaccines. 2015. PMID: 25348036 Review.

2

Evaluation of the ability of N-terminal fragment of lethal factor of Bacillus anthracis for delivery of Mycobacterium T cell antigen ESAT-6 into cytosol of antigen presenting cells to elicit effective cytotoxic T lymphocyte response.

Chandra S, Kaur M, Midha S, Bhatnagar R, Banerjee-Bhatnagar N. Chandra S, et al. Among authors: kaur m. Biochem Biophys Res Commun. 2006 Dec 22;351(3):702-7. doi: 10.1016/j.bbrc.2006.10.099. Epub 2006 Oct 30. Biochem Biophys Res Commun. 2006. PMID: 17084814

3

Induction of cytotoxic T lymphocyte response against Mycobacterial antigen using domain I of anthrax edema factor as antigen delivery system.

Chandra S, Kaur M, Midha S, Gorantala J, Bhatnagar R. Chandra S, et al. Among authors: kaur m. Biochem Biophys Res Commun. 2007 May 25;357(1):50-5. doi: 10.1016/j.bbrc.2007.03.166. Epub 2007 Apr 5. Biochem Biophys Res Commun. 2007. PMID: 17416345

4

Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge.

Kaur M, Rai A, Bhatnagar R. Kaur M, et al. Vaccine. 2009 Mar 26;27(15):2128-37. doi: 10.1016/j.vaccine.2009.01.128. Epub 2009 Feb 6. Vaccine. 2009. PMID: 19356616 Free PMC article.

5

Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.

Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M, Bhatnagar R. Kaur M, et al. Mol Immunol. 2009 Jun;46(10):2107-15. doi: 10.1016/j.molimm.2008.12.031. Epub 2009 Apr 7. Mol Immunol. 2009. PMID: 19356802

6

Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.

Kaur M, Saxena A, Rai A, Bhatnagar R. Kaur M, et al. FASEB J. 2010 Jan;24(1):173-83. doi: 10.1096/fj.09-138644. Epub 2009 Sep 9. FASEB J. 2010. PMID: 19741168

7

Recent progress in the development of anthrax vaccines.

Kaur M, Bhatnagar R. Kaur M, et al. Recent Pat Biotechnol. 2011 Dec;5(3):148-59. doi: 10.2174/187220811797579097. Recent Pat Biotechnol. 2011. PMID: 22360464 Review.

8

A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.

Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S. Manish M, et al. Among authors: kaur m. PLoS One. 2013 Apr 29;8(4):e61885. doi: 10.1371/journal.pone.0061885. Print 2013. PLoS One. 2013. PMID: 23637922 Free PMC article.

9

Anthrax vaccines: present status and future prospects.

Kaur M, Singh S, Bhatnagar R. Kaur M, et al. Expert Rev Vaccines. 2013 Aug;12(8):955-70. doi: 10.1586/14760584.2013.814860. Expert Rev Vaccines. 2013. PMID: 23984963 Review.

10

Alum adjuvanted rabies DNA vaccine confers 80% protection against lethal 50 LD₅₀ rabies challenge virus standard strain.

Garg R, Kaur M, Saxena A, Prasad R, Bhatnagar R. Garg R, et al. Among authors: kaur m. Mol Immunol. 2017 May;85:166-173. doi: 10.1016/j.molimm.2017.02.011. Epub 2017 Mar 6. Mol Immunol. 2017. PMID: 28267643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,724 results

Search Page